Guides & Toolkits
Psoriatic arthritis (PsA) is an immune-mediated inflammatory disease (IMID) that causes inflammation in the joints, resulting in stiffness and pain. PsA can develop at any age, but it is most commonly identified between the ages of 30 and 50, and often occurs in individuals with psoriasis – another IMID that can cause inflammation and overproduction of skin cells, skin discoloration, and/or rashes.
The Society for Women’s Health Research’s Psoriatic Arthritis Toolkit: A Woman’s Empowerment Guide was created to support women living with PsA by providing tips and strategies to address diagnosis, treatment, care coverage, and everyday wellness.
PsA occurs equally in women and men, but women report more severe symptoms of fatigue, widespread pain, and difficulty achieving remission.
Additionally, some health conditions that often occur alongside PsA and disproportionately affect women include: cardiovascular disease, depression, fibromyalgia, inflammatory bowel disease, and osteoporosis.
Learn more by checking out the toolkit’s Glossary, Resources, and References sections.
SWHR’s Psoriatic Arthritis Program was launched in 2021 to address the impact of autoimmune and immune-mediated skin diseases and comorbid conditions such as psoriatic arthritis on women’s health across the lifespan. The Program engages researchers, health care providers, patients, advocates, and health care policy decision-makers to explore strategies to address knowledge gaps, unmet patient needs, and relevant policies that present barriers to equitable and quality care for women living with psoriatic arthritis.
On August 2nd the Senate Appropriations Committee advanced the fiscal year (FY) 2025 Labor, HHS, Education, and Related Agencies Appropriations bill (Labor-HHS). The committee approved the spending bill with a bipartisan 25-3 vote.
When I was 20, I started having joint pain. Initially, I didn't even consider going to the doctor because I knew it would be dismissed, but after a few weeks the pain got so severe I had trouble doing the simplest everyday tasks.
Sharing her insights on autoimmune disease research and OADR's role in tackling them, Victoria Shanmugam, MBBS, MRCP, FACR, CCD, Director of the OADR, presented at the Society for Women's Health Research's (SWHR) March 2024 Policy Advisory Council meeting.
While it is unclear what makes someone more at risk for an autoimmune disease, constructs, such as race and ethnicity, and social determinants of health, including education level, income, and other socioeconomic measures, are known to have an impact on health outcomes.
This document is intended to serve as an educational and informative resource and is not intended or implied to serve as a substitute for medical or professional advice. The Society for Women’s Health Research does not make medical, diagnosis, or treatment recommendations, nor does it endorse or promote specific screening or diagnostic tests. Patients and consumers should confirm information and consult a professional health care provider to determine individual needs. The Society will not be liable for any direct, indirect, or other damages arising therefrom.
SWHR’s Psoriatic Arthritis Program is supported by an educational sponsorship from Eli Lilly & Company. SWHR maintains editorial control and independence over educational content.